Jun 18, 2024
Conversation around how a cardiologist or non-endocrinologist starts GLP-1 RAs. We will explore dose escalation, concerns about hypoglycemia, managing other glucose lowering agents, how to deal with adverse effects and other important topics.
Claim CE Credit at https://bit.ly/3xqdZJg
May 16, 2024
Conversation around the barriers to GLP-1 RAS. Dr. Trudy Gaillard and Dr. Monica Peek discuss adverse effects, cost, strategies when taking with other medications, social determinants of health, and educational support.
May 3, 2024
Conversation around patient selection and GLP-1 RAs. The
speakers will explore the effects of GLP-1 RAs and SGLT-2
inhibitors on clinical outcomes and CVD risk factors.
Claim CE Credit at https://bit.ly/4aSgdzz
Apr 26, 2024
It has been essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness. Dr. Jeff Hsu talks with Dr. Carrie Harvey about the cardiovascular risks with COVID-19, diagnostic tools, clinical manifestations, short...
Apr 18, 2024
In this episode, a panel of experts discuss existing VTE treatment options, algorithms, corresponding safety and efficacy profiles along with safety and efficacy data, and protocols to address treatment pathways.
